{"id":"NCT03271489","sponsor":"AbbVie","briefTitle":"Long-Term Safety Study of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women","officialTitle":"A Phase 3b Study to Evaluate the Long-Term Safety of Elagolix in Combination With Estradiol/Norethindrone Acetate for the Management of Heavy Menstrual Bleeding Associated With Uterine Fibroids in Premenopausal Women","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2017-09-13","primaryCompletion":"2024-06-28","completion":"2024-06-28","firstPosted":"2017-09-05","resultsPosted":"2025-07-22","lastUpdate":"2025-07-22"},"enrollment":478,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Heavy Menstrual Bleeding","Uterine Fibroids"],"interventions":[{"type":"DRUG","name":"Elagolix","otherNames":[]},{"type":"DRUG","name":"Estradiol /norethindrone acetate (E2/NETA)","otherNames":[]},{"type":"OTHER","name":"E2/NETA Placebo","otherNames":[]},{"type":"OTHER","name":"Elagolix Placebo","otherNames":[]}],"arms":[{"label":"Elagolix plus estradiol (E2)/norethindrone acetate (NETA)","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"This randomized multicenter phase 3b study seeks to evaluate the safety of elagolix in combination with estradiol/norethindrone acetate for the management of heavy menstrual bleeding associated with uterine fibroids in premenopausal women. This study was double-blind (DB) during the first 12 months and open-label (OL) for the next 36 months.","primaryOutcome":{"measure":"Number of Participants With Adverse Events (AEs)","timeFrame":"Baseline to 60 months","effectByArm":[{"arm":"Elagolix Plus Estradiol (E2)/Norethindrone Acetate (NETA)","deltaMin":203,"sd":null},{"arm":"Placebo","deltaMin":83,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"FEMALE","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":5},"locations":{"siteCount":157,"countries":["United States","Puerto Rico"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":159},"commonTop":["BONE DENSITY DECREASED","HOT FLUSH","COVID-19","HEADACHE","HYPERTENSION"]}}